Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Q2 Preview: Geo's Keeping Its Eye on the Ball

CLICK HERE TO READ THE FULL REPORT FULL DISCLOSURE: Geodrill Ltd. is a client of Stockhouse Publishing.

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data

EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. ...

The Euro Bulls Are Back: Targets to Eye

EUR/USD The euro has recently rebounded, and the pair is approaching resistance after swift Friday’s action. Will the bulls be strong enough to overcome it – and if so, where exactly can their efforts take them? These were our Friday&CloseCurlyQuo...

TomaGold : A Stock Worth ‘Weighting’ For…

TomaGold Corporation (TSXV: LOT / OTC: TOGOF) is a mineral exploration company that has recently caught my eye. The company is situated quite nicely with some prime real estate. With a head office based in Montreal, it holds interest in five gold properties in Northern Quebec ...

The Next Catalyst for Gold

The precious metals sector remains in a correction, and as long as the 200-day moving averages hold, a bullish consolidation that began last September. Sure, Gold made a new high and is still holding around the previous high, but the rest of the sector has not confirmed th...

Buzz on the Bullboards: Celebrating Success in Difficult Times with an Eye to a Profitable 2021.

As we continue the fight against the COVID-19 pandemic, the recent global rollout of effective vaccines to win the battle against the coronavirus gives us pause to give hope for a better 2021 and reflect on some of the amazing accomplishments both individuals and companie...

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic ey...

After China Trade Deal, Trump Takes Aim at Europe

The Trump administration has taken a tough stance in international trade negotiations. With the US-China deal sealed and Congress set to vote on the US-Mexico-Canada accord, will the European Union be President Trump’s next target? Kenny Fisher ...

Quantum Economics, Negative Interest Rates and Financially Transmitted Diseases

This week the US Federal Reserve announced an emergency rate cut of 0.5% (50bps). It is part of a coordinated effort by central bankers around the world to keep the decade long bull market going a few days longer. Ultra low interest rates and ever depreciating currencie...

Top Cannabis Stocks

If you’re looking to invest in cannabis stocks, there are a couple of different approaches you can take. It helps to look at many types of companies in different parts of the industry and see which looks the most promising for your portfolio. The cannabis s...
1 2 3 4 5 6 7 8 9 10 ...